Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-13 · accession 0001827169-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-13 | INDV | Ryan Barbara | Dir | P - Purchase | $31.09 | +8 | 5,724 | +0.1% | +$248.72 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-13 | P | A | 8 | $31.09 | 5,724 | D | — | — |